Your Invited to a special CEO Talks event to hear from these serial Biotech Entrepreneurs

Greetings!

We would like to invite you to a special event to join other industry leaders and peers to celebrate a year of growth within our entrepreneurial ecosystem and the greater Biohealth Capital Region.

Several of the region's top startup executives will participate in an engaging discussion and share the lessons they have learned along their journeys in building their past and current companies.

 

NewImage

A pair of Baltimore teams focused on medication use are joining forces in the quest to ensure patients follow their prescribed plans.

Tech company emocha Mobile Health and the Baltimore-based University of Maryland School of Pharmacy’s Center for Innovative Pharmacy Solutions are collaborating to offer a medication review that combines pharmacists and a mobile app. This will be offered as emocha expands to hospitals, health systems and health insurers, said CEO Sebastian Seigeur.

“This is now our standard,” he said.

Image: Telehealth at the University of Maryland School of Pharmacy's eHealth Center. (Courtesy photo)

Biotalk SkyScraper Barrow

Recorded at the BioHealth Capital Region Investor Forum: Christian Barrow, Executive Director of Life Sciences Banking with JPMorgan Chase, guests on BioTalk to talk about his background working with life science companies, healthcare Investing, and the BioHealth Capital Region.

Listen now on Apple Podcasts https://apple.co/35zhnxI, Google Podcasts http://bit.ly/34kY1MP, and TuneIn http://bit.ly/2QQScTs

Chris Barrow is a senior banker with J. P. Morgan commercial bank. Chris joined J.P. Morgan in 2012 in the Philadelphia office, where he and his team focus on providing financial solutions to life sciences companies located in the Mid-Atlantic - Delaware, Pennsylvania and Maryland. Chris has over 25 years of experience in the financial services industry with roles that have spanned from public accounting to banking.

Chris’ current job is to help life science companies – biotech, specialty pharmaceutical, specialty pharmacy, medical device, med-tech, medical diagnostics and contract research organizations – gain access to JPMorgan’s well-known healthcare commercial and investment banking resources.

Prior to his current role, Chris started his career with EY (inactive CA and CPA licenses). He subsequently served as a senior banker for Bank of America. In this capacity, he was responsible for origination and structuring of debt products to general industry companies located in Pennsylvania.

Chris holds a bachelor’s degree in Biology and a graduate diploma in Accounting both from McGill University. He currently resides in Doylestown, Pennsylvania with his wife and two children.

 
5 women

Venture capital has something of a reputation as a boys’ club, but there are women making their mark in this field. In particular, five women have been singled out for their contributions to the life sciences industry.

Bio Buzz selected five women venture capitalists who are considered “trailblazing investors shaping the future of life science investing” in the BioCapital Hotbed Community, which includes Delaware, Maryland, Virginia and Washington, D.C.

 

NextGen Venture Partners has raised a second fund Washington Business Journal

NextGen Venture Partners reported Tuesday that it raised more than $42 million for its second fund, nearly double its initial haul three years ago.

The $42.68 million in new funding comes about a year after the venture firm first indicated plans to raise a fund, according to a Securities and Exchange Commission filing. Though, those efforts were delayed by its acquisition in early 2018 by Baltimore investment giant Brown Advisory. While Tuesday's filing lists Brown Advisory CEO Michael Hankin as the top executive, NextGen co-founders Dan Mindus and Brett Gibson both remain managing partners, per the website, and still work in the D.C. area, according to their LinkedIn profiles.

 

Top Ten Best Hit Free image on Pixabay

Alex Trebek appeared well en route to surviving pancreatic cancer this past summer when his doctors followed up his initial successful chemotherapy with an undisclosed immunotherapy. That move backfired.

“I was doing so well. And my numbers went down to the equivalent of a normal human being who does not have pancreatic cancer. So we were all very optimistic. And they said, ‘Good, we’re gonna stop chemo, we’ll start you on immunotherapy,” Trebek said September 17 on ABC’s Good Morning America. “I lost about 12 pounds in a week. And my numbers went sky-high, much higher than they were when I was first diagnosed.”

 

writing 1149962 640

BHI is seeking a full time energetic and motivated individual with relevant marketing experience and an interest in growing with our organization to serve as our full time Marketing and Communications Coordinator. The Marketing and Communications Coordinator will perform a variety of duties that support the organization’s mission, including formulating and executing a strategic marketing plan for the organization that encompasses BHI’s goals for the next three years and providing ongoing marketing collateral creation and marketing administrative support.

Click here for more information.

 
alexandria logo

A consortium of leaders from Boston’s biggest research institutions are joining forces on advancing biological manufacturing and innovation. 

Executives from Harvard University, the Massachusetts Institute of Technology, Fujifilm Diosynth Biotechnologies, GE Healthcare Life Sciences and Alexandria Real Estate Equities will serve as the board of directors of a planned $50M center of advanced biological innovation and manufacturing, the group announced Monday.

Image: Wikimedia Commons/Joseph Williams Harvard University's Widener Library

PTL Logo

GERMANTOWN, Md. - Sept. 10, 2019 - PRLog -- Primetime Life Sciences, LLC,  a Maryland based pharmaceutical company focused on discovery and development of new and smart treatments, announced today that the company has successfully met the Phase I grant milestones, and has been awarded Phase II funding of $2.63 million from a Fast Track Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health (NIMH). The SBIR program supports scientific excellence and technological innovation by encouraging small businesses to engage in translation research and bring innovative treatments.

 

Kurt Newman M D Children s National Hospital

I have spent decades as a health-care executive and pediatric surgeon. I am often asked to reflect on the biggest advancements that have been developed to save children’s lives. 

While I can acknowledge that there are many technologies available to surgeons today that did not exist when I first began operating, I can’t ignore the fact that innovation in medical devices and technology for children continues to occur much more slowly than it does for adults. 

Image: https://thehill.com

Pumpkin Thanksgiving Meal Free photo on Pixabay

Happy Thanksgiving from Rich Bendis and the BHI Team!

ZIDDANDFIZZ

Usually BioHealth Founder and CEO, Rich Bendis, is the host asking questions of his guests on the BioTalk Podcast. However, Rich was recently a guest on the “The ZIDDANDFIXX Show: Angels Talk” Podcast for their 26th Episode titled “The Golden Triangle: DC joins San Francisco and Boston.” They discussed Venture Capital, Angel Investment, and the BioHealth Capital Region.

Ziad Moukheiber of Boston Harbor Angels (East Coast), and Faz Bashi (West Coast) of Life Science Angels have a good time chatting about Angel Investing, Entrepreneurship, Restaurants, Politics with good friends and always with great humor and lots of laughter!

Listen now!

 
Biotalk SkyScraper Barrow

Recorded at the BioHealth Capital Region Investor Forum: Christian Barrow, Executive Director of Life Sciences Banking with JPMorgan Chase, guests on BioTalk to talk about his background working with life science companies, healthcare Investing, and the BioHealth Capital Region.

Listen now on Apple Podcasts https://apple.co/35zhnxI, Google Podcasts http://bit.ly/34kY1MP, and TuneIn http://bit.ly/2QQScTs

Chris Barrow is a senior banker with J. P. Morgan commercial bank. Chris joined J.P. Morgan in 2012 in the Philadelphia office, where he and his team focus on providing financial solutions to life sciences companies located in the Mid-Atlantic - Delaware, Pennsylvania and Maryland. Chris has over 25 years of experience in the financial services industry with roles that have spanned from public accounting to banking.

Chris’ current job is to help life science companies – biotech, specialty pharmaceutical, specialty pharmacy, medical device, med-tech, medical diagnostics and contract research organizations – gain access to JPMorgan’s well-known healthcare commercial and investment banking resources.

Prior to his current role, Chris started his career with EY (inactive CA and CPA licenses). He subsequently served as a senior banker for Bank of America. In this capacity, he was responsible for origination and structuring of debt products to general industry companies located in Pennsylvania.

Chris holds a bachelor’s degree in Biology and a graduate diploma in Accounting both from McGill University. He currently resides in Doylestown, Pennsylvania with his wife and two children.

 
Your Invited to a special CEO Talks event to hear from these serial Biotech Entrepreneurs

Greetings!

We would like to invite you to a special event to join other industry leaders and peers to celebrate a year of growth within our entrepreneurial ecosystem and the greater Biohealth Capital Region.

Several of the region's top startup executives will participate in an engaging discussion and share the lessons they have learned along their journeys in building their past and current companies.

 

The National Foundation for Cancer Research Announces Expansion of Scientific Advisory Board

BETHESDA, Md., Oct. 14, 2015 /PRNewswire-USNewswire/ -- The National Foundation for Cancer Research (NFCR) today announced the expansion of its Scientific Advisory Board. The NFCR Scientific Advisory Board includes Webster Cavenee, PhD, Chair; Frederick W. Alt, PhD; Ruggero De Maria, PhD; Kanaga Sabapathy, PhD; and Peter Vogt, PhD.

The mission of the NFCR Scientific Advisory Board is to provide scientific, strategic, and clinical guidance and direction for NFCR basic science and translational research programs. Directed by Webster Cavenee, PhD, the NFCR Scientific Advisory Board is comprised of leaders in cancer research who have made significant breakthroughs in the diagnosis and treatment of cancer, scientists who are committed to furthering NFCR's unwavering commitment to funding research that will cure cancer—all types of cancer.

 

NewImage

After a long suspenseful day, University of Maryland, Baltimore County earned the top spot as national winner of the U.S. Department of Energy's CyberForce Competition.

The U.S. Department of Energy (DOE) announced University of Maryland, Baltimore County as the national winner of DOE's fifth CyberForce Competition™, held on November 16, 2019 at 10 of the national laboratories across America. The competition challenged 105 collegiate teams to build simulated energy infrastructure and defend it from cyberattacks. Regional first place winners were recognized by each participating laboratory.

Image: CAPTION The team from University of Maryland, Baltimore County won the national DOE CyberForce Competition over the weekend, besting more than 100 teams from 10 national laboratories across the country. CREDIT Argonne National Laboratory

NewImage

The A. James Clark School of Engineering at the University of Maryland has produced remarkable engineers, scientists, life science professionals and entrepreneurs that have shaped the Biohealth Capital Region (BHCR) for well over a century. 2019 marks the Clark School’s 125th anniversary as one of the most important STEM talent pipelines in the region and nation.

Image: https://biobuzz.io

money

Configo Health, a company developing artificial intelligence-powered data analytics solutions for pediatric healthcare facilities, launched Nov. 18 with the announcement of Texas Children's Hospital and Children's National Hospital as founding investors.

Configo Health extracts administrative data from pediatric hospitals to create a comprehensive dataset of near-real-time benchmarked data. The HIPAA-protected information is available for use by patients, public ratings organizations and pediatric care facilities, which can use the compiled performance data to reduce readmissions and improve outcomes.

 

vor maxcyte

 

CAMBRIDGE, Mass. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and MaxCyte, Inc., a global cell-based therapies and life sciences company, today announced a clinical and commercial license agreement under which Vor will use MaxCyte’s Flow Electroporation® technology to produce eHSCs and initiate Investigational New Drug (IND)-enabling studies to accelerate its progress towards the clinic.

 

emmes logo

ROCKVILLE, Md., Nov. 25, 2019 /PRNewswire/ -- Emmes today announced that Lynn Lewis has joined the company as chief business officer, a newly created position.  Her overall focus is to build deeper relationships with existing clients and to develop new business opportunities, particularly among biotech and pharmaceutical companies.

Lewis will be responsible for sales, marketing, communications, strategic planning and partnerships, and proposal development.

Dr. Anne Lindblad, president and chief executive officer of Emmes, said, "Lynn understands the importance of science in our business.  She will extend our reputation and value as a trusted scientific partner with those who share our passion for designing and executing important studies aimed at improving human health."

 

Alexandria® Building the Future of Life Science™

Plans are moving forward for another Bay Area biotech campus. Alexandria Real Estate Equities is transforming a chunk of property in San Carlos into a 1.6 million-square-foot biotech campus.

According to the San Francisco Business Times, the real estate development company submitted plans for its proposed biotech campus. The site in question includes multiple office buildings, including the former corporate headquarters of Kelly-Moore Paints. Most of the buildings on the swath of property are decades old. Alexandria Real Estate Equities intends to turn the space into six new buildings, each about five to seven floors for biotech companies to use. In addition to the buildings, the site will also include an amenities structure, parking garages and a small park, according to the Business Times.

 

NewImage

"I'm thrilled to be joining Deloitte and continue to follow my passion for understanding how data science methods and technologies can be applied to biomedical data to yield a better understanding of biology," Bonazzi said. "I'm looking forward to supporting agencies in their mission to utilize data science to better understand and use complex biomedical data."

 

Virginia Tech focuses on entrepreneurship WVNS

BLACKSBURG, VA (WVNS) — A program at Virginia Tech empowers students with knowledge and skills to build or launch companies. According to a release, the Apex Center for Entrepreneurship is on track to engage more than 3,000 students across the college campus.

Apex Director Sean Collins shared that the center is building the 21st century workforce, and is helping entrepreneurs work in cross-functional teams, navigate ambiguity, assess risk, and build new technology fluency.

Image: https://www.wvnstv.com

NewImage

ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) last Thursday, November 14, conducted its latest Salisbury Award Competition for Entrepreneurial Translational Research. This event featured 16 individual cancer research projects from 15 institutions, selected from among a total of 36 applications. It concluded with an evening ceremony at which finalists were recognized, the winner and runners-up were named and the founding Salisbury family of NFCR was honored.

Image: Representatives of the 16 selected cancer research projects, among 36 applicants, who participated in the Salisbury Award Competition. - https://www.nfcr.org

The Netherlands Delivers New Headquarters to EMA NFIA

The Netherlands has officially delivered the new Amsterdam headquarters to the European Medicines Agency (EMA). The new office, located in the Zuidas area of Amsterdam, will enable EMA to continue carrying out their activities by assessing medicines without any interruption. Minister Bruno Bruins (Health, Care and Sports) complimented all parties involved with this special achievement, as the new build was completed within a very short time frame: “It is a beautiful and important achievement that EMA will be able to move in this new building in time as promised. Built at a high pace and in a very short time frame.

Image: https://investinholland.com - from video

NewImage

A group of academic, biotech, biopharma, and healthcare leaders at Harvard and across Massachusetts plan to create a new center for innovation and manufacturing next-generation medicines, according to a Monday press release.

The center, which is estimated to cost $50 million dollars, will be an independent non-profit located in the Greater Boston area. The board of directors of the new center includes leaders from Harvard, MIT, Fujifilm Diosynth Biotechnologies, GE Healthcare Life Sciences, and Alexandria Real Estate Equities, Inc.

Image: Senior members of Harvard's central administration, including University Provost Alan M. Garber '76, work in Massachusetts Hall. Photo: Sydney R. Mason

Laboratory Scientists Research Free photo on Pixabay

From gene editing to microfluidics, the scope for innovation in the field of life sciences is vast and ever-expanding. Yet many researchers don’t know how to make the leap from academia to industry.

Concordia’s District 3 aims to do something about that.

The District 3 Innovation Centre is working with the City of Montreal to help the biosciences and life sciences industries address shortages of scientific talent, as well as to train graduates who seek jobs to match their skill set.

 

Pills Medicine Medical Free image on Pixabay

Headwinds ranging from an expected renewal of political wrangling over the price of prescription drugs to increasing pressure on sales of established treatments have largely, but not entirely, kept pharmaceutical companies from enjoying the increases of their biotech counterparts, as reflected in the share prices of exchange-traded funds (ETFs) consisting of pharma equities.

 

Handshake Hand Give Free photo on Pixabay

Qiagen NV shares jumped the most in 17 years after people with knowledge of the matter said Thermo Fisher Scientific Inc. is considering a takeover of the molecular testing firm.

Thermo Fisher has approached the Dutch company about a potential purchase that could become one of its biggest-ever acquisitions, the people said, asking not to be identified because the information is private. Shares of Qiagen rose 13% to 33.20 euros at 1:10 p.m. in Frankfurt, giving it a market value of $8.3 billion.

 

writing 1149962 640

BHI is seeking a full time energetic and motivated individual with relevant marketing experience and an interest in growing with our organization to serve as our full time Marketing and Communications Coordinator. The Marketing and Communications Coordinator will perform a variety of duties that support the organization’s mission, including formulating and executing a strategic marketing plan for the organization that encompasses BHI’s goals for the next three years and providing ongoing marketing collateral creation and marketing administrative support.

Click here for more information.

 
Sara Gilgore

Virginia Tech is coming to Children’s National Hospital’s new campus at the former Walter Reed Army Medical Center.

The partnership will bring a 12,000-square-foot biomedical research complex to the 12-acre Children’s National Research and Innovation Campus, slated to deliver in December 2020 as part of the project’s first phase. In the university's first D.C. location, Virginia Tech's Fralin Biomedical Research Institute at Virginia Tech Carilion will establish a D.C. team to work with Children’s National on translational research projects, faculty recruiting, intellectual property work and commercialization, and trainings for students and fellows — all focused on pediatric cancers of the brain and nervous system.

 

CEO Chat Lessons Learned from Successful Biotech Entrepreneurs

Join us for a final event of the year where several of the region’s experienced entrepreneurs will share the lessons they have learned along their journeys in building their current and past companies.

Hear from an amazing panel of entreprenurs who have collectively been founders and CxO's of 12 companies, raised hundreds of millions of dollars and negotiated more than a half dozen acquisitions and exits.